JP2024544067A5 - - Google Patents
Info
- Publication number
- JP2024544067A5 JP2024544067A5 JP2024532266A JP2024532266A JP2024544067A5 JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5 JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5
- Authority
- JP
- Japan
- Prior art keywords
- chemically modified
- modified oligonucleotide
- oligonucleotide according
- bonds
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21211372 | 2021-11-30 | ||
| EP21211372.4 | 2021-11-30 | ||
| PCT/EP2022/083711 WO2023099494A1 (en) | 2021-11-30 | 2022-11-29 | Antisense oligonucleotides (aso) for efficient and precise rna editing with endogenous adenosine deaminase acting on rna (adar) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544067A JP2024544067A (ja) | 2024-11-27 |
| JP2024544067A5 true JP2024544067A5 (cg-RX-API-DMAC10.html) | 2025-12-11 |
Family
ID=78820190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532266A Pending JP2024544067A (ja) | 2021-11-30 | 2022-11-29 | Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso) |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230235329A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4441216A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024544067A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240111752A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118355119A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022399905A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3238033A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312762A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023099494A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250101418A1 (en) * | 2022-11-30 | 2025-03-27 | Eberhard-Karls-Universität-Tübingen | Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing |
| EP4762176A1 (en) * | 2023-08-15 | 2026-06-24 | Airna Corporation | Chemically modified antisense oligonucleotides (asos) and compositions for rna editing |
| WO2025073902A1 (en) * | 2023-10-06 | 2025-04-10 | Eberhard Karls Universität Tübingen | Chemical and sequence optimisation of antisense oligonucleotides for adar-mediated rna editing |
| WO2025172372A1 (en) | 2024-02-12 | 2025-08-21 | Airna Corporation | Conjugate for targeted delivery of an antisense oligonucleotide |
| WO2025242018A1 (zh) * | 2024-05-20 | 2025-11-27 | 时夕(广州)生物科技有限公司 | 一种经修饰的向导agRNA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018041973A1 (en) * | 2016-09-01 | 2018-03-08 | Proqr Therapeutics Ii B.V. | Chemically modified single-stranded rna-editing oligonucleotides |
| WO2020001793A1 (en) | 2018-06-29 | 2020-01-02 | Eberhard-Karls-Universität Tübingen | Artificial nucleic acids for rna editing |
| US20230039928A1 (en) * | 2019-12-23 | 2023-02-09 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease |
-
2022
- 2022-11-29 IL IL312762A patent/IL312762A/en unknown
- 2022-11-29 EP EP22823405.0A patent/EP4441216A1/en active Pending
- 2022-11-29 CA CA3238033A patent/CA3238033A1/en active Pending
- 2022-11-29 JP JP2024532266A patent/JP2024544067A/ja active Pending
- 2022-11-29 KR KR1020247016720A patent/KR20240111752A/ko active Pending
- 2022-11-29 WO PCT/EP2022/083711 patent/WO2023099494A1/en not_active Ceased
- 2022-11-29 AU AU2022399905A patent/AU2022399905A1/en active Pending
- 2022-11-29 CN CN202280079432.9A patent/CN118355119A/zh active Pending
- 2022-11-30 US US18/071,999 patent/US20230235329A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025165976A5 (cg-RX-API-DMAC10.html) | ||
| JP2021512629A5 (cg-RX-API-DMAC10.html) | ||
| JP2022550915A5 (cg-RX-API-DMAC10.html) | ||
| JP2024038326A5 (cg-RX-API-DMAC10.html) | ||
| AU2020290517B2 (en) | Antisense RNA editing oligonucleotides comprising cytidine analogs | |
| US5696253A (en) | Polynucleoside chain with 3'→5' guanidyl linkages | |
| DE60038495T2 (de) | Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung | |
| JP2024038327A5 (cg-RX-API-DMAC10.html) | ||
| JP2024088642A5 (cg-RX-API-DMAC10.html) | ||
| US7989603B2 (en) | 2′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and use | |
| US11584773B2 (en) | Phosphorous protecting groups and methods of preparation and use thereof | |
| US5969116A (en) | Nucleosides and oligonucleotides having 2'-ether groups | |
| JP2022532169A5 (cg-RX-API-DMAC10.html) | ||
| US20170247695A1 (en) | Isotopologues of smad7 antisense oligonucleotides | |
| JP2022527814A5 (cg-RX-API-DMAC10.html) | ||
| JPH07300493A (ja) | 2′−エーテル基を有する、ヌクレオシド及びオリゴヌクレオチド | |
| JP2001103987A (ja) | 高いキラル純度のホスホロチオエート結合を有するオリゴヌクレオチド | |
| JPH0813274B2 (ja) | 遺伝子発現を検出及び変調する糖修飾されたオリゴヌクレオチド | |
| JPH06511492A (ja) | キラルリン結合を有するオリゴヌクレオチド | |
| JP2024545602A5 (cg-RX-API-DMAC10.html) | ||
| JP2021511072A5 (cg-RX-API-DMAC10.html) | ||
| JP2024543963A5 (cg-RX-API-DMAC10.html) | ||
| JP2024544067A (ja) | Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso) | |
| DE69725440T2 (de) | 2-substituierte nukleosid- und oligonukleotid- derivate | |
| JP2023526057A5 (cg-RX-API-DMAC10.html) |